SAN DIEGO, Feb. 13, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® is proud to support all United States military veterans with exclusive discounts on its cannabidiol (CBD) hemp oil products.
As recently reported by CNBC, more than 42,000 Americans died due to opioid overdose in 2016 and recent studies have found that veterans were twice as likely to die from an opioid overdose compared to the rest of the population.
Cannabis use for veterans has become more widely accepted in recent months, especially as a treatment for addiction, with an announcement by the Department of Veterans Affairs (VA) stating that “Veteran participation in state marijuana programs does not affect eligibility for VA care and services.” A new guidance issued in December 2017 directs VA staff and pharmacists to discuss how medical marijuana interacts with other medications or facets of their care, including treatment for pain management or post-traumatic stress disorder.
“We view all of our customers as heroes who are helping us spread the important message of the potential health and wellness benefits of CBD,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Veterans are an entirely different type of hero, not only because they have risked their lives for the safety of Americans, but also because they have protected our right to spread awareness about CBD and the many uses of cannabis and hemp.”
Military personnel and veterans who shop at the HempMeds® online store receive a 15% discount on all purchases and free shipping. HempMeds®, the first company to ever bring hemp-based CBD oil products to market in the U.S and make CBD products available in bulk, is honored to offer this discount to those who have fought for the wellbeing and safety of United States citizens.
Veterans can find more information at https://hempmedspx.com/cbd-oil-veterans/.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media